Cargando…

Offshore Pharmaceutical Trials: Evidence, Economics, and Ethics

Detalles Bibliográficos
Autores principales:	Yang, Y. Tony, Chen, Brian, Bennett, Charles L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132216/ https://www.ncbi.nlm.nih.gov/pubmed/30225454 http://dx.doi.org/10.1016/j.mayocpiqo.2018.04.002

Ejemplares similares

Ethics, emergencies and Ebola clinical trials: the role of governments and communities in offshored research
por: Folayan, Morenike Oluwatoyin, et al.
Publicado: (2015)

Ethics, Evidence and Economics in the Pursuit of “Personalized Medicine”
por: Lewis, Jan, et al.
Publicado: (2014)

Economics and industry do not mean ethical conduct in clinical trials
por: Lexchin, Joel
Publicado: (2013)

Allo-parapatric speciation goes offshore
por: Price, Trevor
Publicado: (2019)

Ethics and Economics of the COVID-19 Pandemic in the United States
por: Hilsenrath, Peter, et al.
Publicado: (2020)

Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions
por: Tomažič, Tina, et al.
Publicado: (2019)

UK offshore immigration detention: why the medical community should act now
por: Essex, Ryan, et al.
Publicado: (2021)

Adaptive trials, efficiency, and ethics
por: Hey, Spencer Phillips
Publicado: (2019)

Ethics and evidence based research: Is there a conflict?
por: Agrawal, Karoon
Publicado: (2013)

Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method
por: Rogers, Amy, et al.
Publicado: (2020)

Universal masking for COVID-19: evidence, ethics and recommendations
por: Chan, Tak Kwong
Publicado: (2020)

Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)

Changing patient preferences toward better trial recruitment: an ethical analysis
por: Al, Pepijn, et al.
Publicado: (2023)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

COVID-19 vaccine trials with children: the Jewish ethics
por: Rashi, Tsuriel
Publicado: (2022)

Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings
por: Joag, Kaustubh, et al.
Publicado: (2019)

A Software for Calculating the Economic Aspects of Floating Offshore Renewable Energies
por: Castro-Santos, Laura, et al.
Publicado: (2019)

The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010)

An Evidence-Based Ethical Approach to Parental Refusal of Screening Tests: The Case of Asymptomatic Neonatal Hypoglycemia
por: Palmaccio, Samantha J., et al.
Publicado: (2021)

Ethics of COVID-19 vaccine trials in rapidly changing contexts
por: Knottnerus, J. André
Publicado: (2021)

Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive Analysis
por: Chen, Brian K., et al.
Publicado: (2016)

Ethical issues in cluster randomized trials conducted in low- and middle-income countries: an analysis of two case studies
por: Choko, Augustine T., et al.
Publicado: (2020)

Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy
por: Oteba, Martin, et al.
Publicado: (2018)

The ethical analysis of risk in intensive care unit research
por: Weijer, Charles
Publicado: (2004)

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group
por: Chan, Kelvin K. W., et al.
Publicado: (2021)

Ethics of randomised controlled trials – not yet time to give up on equipoise
por: Ashcroft, Richard E
Publicado: (2004)

Vaccine trials during a pandemic: potential approaches to ethical dilemmas
por: Alqahtani, Manaf, et al.
Publicado: (2021)

Navigating ethical challenges of conducting randomized clinical trials on COVID-19
por: Kaye, Dan Kabonge
Publicado: (2022)

Ethics in Trichology
por: Padmanabhan, Parvathi
Publicado: (2010)

Shifts in UNAIDS ethics guidance and implications for ethics review of preventive HIV vaccine trials
por: Slack, Catherine, et al.
Publicado: (2021)

Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer Medicine
por: Prasad, Vinay, et al.
Publicado: (2015)

Ending the evidence gap for pregnancy, HIV and co‐infections: ethics guidance from the PHASES project
por: Lyerly, Anne Drapkin, et al.
Publicado: (2021)

Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015)

Ethics of Adoption and Use of the Linear No-Threshold Model
por: Yanovskiy, Moshe, et al.
Publicado: (2019)

Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic
por: Suzuki, Shota, et al.
Publicado: (2020)

Ethical priorities for international collaborative adaptive platform trials for public health emergencies
por: Wright, Katharine, et al.
Publicado: (2023)

Allocating Vaccines in a Pandemic: The Ethical Dimension
por: Wu, Joseph H., et al.
Publicado: (2020)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pvtv787dbbnrup24iodec48vvc